Dawn Snyder is an attorney as well as a regular contributor at Injury Lawyer News. Her special areas of interest include the relationship between the FDA and the pharmaceutical companies, circumstances surrounding voluntary recalls, and the settlement process.
Researchers have known about the celiac disease-mimicking Benicar side effects for some time now but a new report highlights an extreme case. Earlier this year, the medical journal Gastrointestinal Medicine reported a case study of a 52-year-old woman suffering from sprue-like enteropathy – a severe gastrointestinal... Read More
Pennsylvania researchers recently published a study that emphasizes the dangers of excessive bleeding associated with anticoagulants. The search for a cure for Xarelto brain bleeds and bleeding events caused by other similar-acting blood thinners has kept researchers busy since Pradaxa entered the market in late... Read More
According to a new report, an investigation by the British Medical Journal suggests that manufacturer Boehringer Ingelheim withheld evidence of Pradaxa bleeding events from government regulators. Without access to the undisclosed drug risk information, the Federal Drug Administration (FDA) and foreign regulators approved the use... Read More
On May 15, 2014, three men who live in California and Delaware filed a testosterone class action lawsuit in the U.S. District Court for the Central District of California. The lawsuit names as defendants the nutritional supplement chain GNC, as well as a number of... Read More
On May 22, 2014, a jury returned a verdict in favor of the manufacturer defendant in a Las Vegas Actos trial. The suit was filed by two women who developed bladder cancer after taking the diabetes drug. The women sought $60 million in compensatory damages... Read More
